View Archive »
About The Cover
The cover for issue 54 of Oncotarget features Figure 5, "A pictorial summary of results of Dox-induced elevated oxidative stress and neurochemical alterations in the periphery and brain as well as cognitive decline (left) and MESNA-mediated protection against these Dox-facilitated effects in both plasma and brain," by Keeney, et al.
|
|
Table of Contents
Editorial Essay
|
| Does rapamycin slow down time |
|
https://doi.org/10.18632/oncotarget.25788
|
| 30210-30212 |
Research Papers: Pathology
|
| Gαi3 signaling is associated with sexual dimorphic expression of the clockcontrolled output gene Dbp in murine liver |
|
https://doi.org/10.18632/oncotarget.25727
|
| 30213-30224 |
Research Papers: Immunology
|
| Highthroughput sequencing of murine immunoglobulin heavy chain repertoires using single side unique molecular identifiers on an Ion Torrent PGM |
|
https://doi.org/10.18632/oncotarget.25493
|
| 30225-30239 |
Research Papers
|
| Lamp2 inhibits epithelialmesenchymal transition by suppressing Snail expression in HCC |
|
https://doi.org/10.18632/oncotarget.25367
|
| 30240-30252 |
|
| Transcriptome profiling of antimüllerian hormone treated preantral/small antral mouse ovary follicles |
|
https://doi.org/10.18632/oncotarget.25572
|
| 30253-30267 |
|
| Noninvasive visualization of tumor infiltrating lymphocytes in patients with metastatic melanoma undergoing immune checkpoint inhibitor therapy: a pilot study |
|
https://doi.org/10.18632/oncotarget.25666
|
| 30268-30278 |
|
| The DNApolymorphism rs849142 is associated with skin toxicity induced by targeted antiEGFR therapy using cetuximab |
|
https://doi.org/10.18632/oncotarget.25689
|
| 30279-30288 |
|
| Autophagy processes are dependent on EGF receptor signaling |
|
https://doi.org/10.18632/oncotarget.25708
|
| 30289-30303 |
|
| Prosopis juliflora Sw DC induces apoptosis and cell cycle arrest in triple negative breast cancer cells: in vitro and in vivo investigations |
|
https://doi.org/10.18632/oncotarget.25717
|
| 30304-30323 |
|
| Doxorubicininduced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapyinduced cognitive impairment “chemobrain†|
|
https://doi.org/10.18632/oncotarget.25718
|
| 30324-30339 |
|
| CAPER as a therapeutic target for triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.25719
|
| 30340-30354 |
|
| Risk factors for locoregional recurrence in breast cancer patients: a retrospective study |
|
https://doi.org/10.18632/oncotarget.25735
|
| 30355-30362 |
|
| RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance |
|
https://doi.org/10.18632/oncotarget.25744
|
| 30363-30384 |
|
| Differential genomics and transcriptomics between tyrosine kinase inhibitorsensitive and resistant BCRABLdependent chronic myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.25752
|
| 30385-30418 |
|
| Viral DNA integration and methylation of human papillomavirus type 16 in highgrade oral epithelial dysplasia and head and neck squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25754
|
| 30419-30433 |
|
| cAMPmediated autophagy inhibits DNA damageinduced death of leukemia cells independent of p53 |
|
https://doi.org/10.18632/oncotarget.25758
|
| 30434-30449 |
|
| Chk1 inhibition as a novel therapeutic strategy in melanoma |
|
https://doi.org/10.18632/oncotarget.25765
|
| 30450-30464 |
|
| PDL1 expression comparison between primary and relapsed nonsmall cell lung carcinoma using whole sections and clone SP263 |
|
https://doi.org/10.18632/oncotarget.25770
|
| 30465-30471 |
Corrections
|
| Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol limits tumor growth and improves survival in immune competent mice |
|
https://doi.org/10.18632/oncotarget.25791
|
| 30472-30472 |
|
| Correction: Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.25792
|
| 30473-30473 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
